Printer Friendly

National Institute of Technology and Evaluation, Astellas Pharma, Chugai Pharmaceutical to Collaborate in Searching Microorganisms in Vietnam.

Tokyo, Japan, Nov 2, 2005 - (JCNN) - The National Institute of Technology and Evaluation (NITE) announced on November 2 that it has launched an industry-government project for searching microorganisms in Vietnam through collaboration with Astellas Pharma and Chugai Pharmaceutical.

Specifically, the three partners will send researchers to Vietnam, who will stay there from November through December and collect samples in the central region. Then, they will isolate microorganisms from the samples using the facilities of the Vietnam National University in Hanoi.

The isolated organisms will be transferred to Japan under a treaty Japan signed with the Vietnamese government concerning the protection and continued use of genetic resources. They will be provided to Astellas Pharma and Chugai Pharmaceutical, and they will strive to identify lead compounds for drug discovery.

Upon successful patent registration or commercialization resulting from findings, the companies will pay Vietnam a part of the profits they will generate through commercial activities.

This project is part of the "Construction of a Genetic Resource Library of Unidentified Microbes Based on Genome Information" project organized by the New Energy and Industrial Technology Development Organization (NEDO).

Source: JCN http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Nov 2, 2005
Words:199
Previous Article:Schering-Plough's TEMODAL Capsule for Glioblastoma Multiforme Granted Priority Review by Government.
Next Article:Info Plant Surveys Peoples Activities on Trains.


Related Articles
Astellas Pharma, MerLion Pharmaceuticals Sign Joint Research Agreement for Naturally-derived Drug Candidate Search.
Astellas Pharma, Theravance to Enter into Licensing Agreement for Investigational Antibiotic Telavancin.
Astellas and Toyama Chemical Announce Basic Licensing Agreement on Domestic Marketing and Joint Development of Quinolone Antibiotic T-3811.
Astellas Establishes New Subsidiary 'Astellas Pharma Chemicals Co., Ltd.'.
Ilypsa and Astellas Enter a Licensing Agreement on ILY101 for Treatment of Hyperphosphatemia in Japan.
Astellas Discontinues Development of Immunosuppressant FK778.
ASTELLAS' SCREENING TRIGGERS MILESTONE PAYMENT TO METABOLEX.
Astellas Transfers Three European Plants to Temmler Group, German Pharmaceutical Company.
Kirin and Astellas Enter Into Licensing Agreement on Immunosuppressive Fully Human Monoclonal Antibody.
Astellas and Pfizer Reached Settlement on Declaratory Judgment Action Relating to Lipitor Agreement.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters